Send feedback

MRAS p.Ser4=

c.12C>T · rs35056274 · VCV1427167

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0443%, afr)
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.4GERP 3.2, phastCons 0.04
Overall
CADD12.24PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0443% African / African-American · 31/70,054 alleles
Filtering AF 0.032% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0278%
Overall 0.0022% 34/1,542,940 alleles · ultra-rare exomes 15/1,390,616 · genomes 19/152,324 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0443% 2,260
Remaining individualsnot grpmax-eligible 0.00336% 29,723
European (non-Finnish) 8.67e-05% 1,152,794

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MRAS
Protein
p.Ser4=
Coding
c.12C>T
MANE Select
NM_001085049
dbSNP
rs35056274
Type
single nucleotide variant
Location
chr3:138372895 (GRCh38)
Gene constraint
LOEUF 0.444 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 86.61 · 11 PDB
Full MRAS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mras-p-ser4 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown